FDA.reportPublic FDA data

Cytomel 50 MCG Oral Tablet

RxCUI
903705
RxNorm name
Cytomel 50 MCG Oral Tablet
Display name
Cytomel 50 MCG Oral Tablet
Full name
Cytomel 50 MCG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CytomelLIOTHYRONINE SODIUMPfizer Laboratories Div Pfizer Inc51452b31-ff68-4e0c-b982-c15502ebf1d32026-05-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 903705

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
51452b31-ff68-4e0c-b982-c15502ebf1d3CYTOMEL 50 MCG Oral Tablet [PSN] · liothyronine sodium 0.05 MG Oral Tablet [Cytomel] [SBD] · Cytomel 0.05 MG Oral Tablet [SY] · Cytomel 50 MCG Oral Tablet [SY]415These highlights do not include all the information needed to use CYTOMEL safely and effectively. See full prescribing information for CYTOMEL. CYTOMEL ® (liothyronine sodium) tablets, for oral use Initial U.S. Approval: 195620260518